About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06854120

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with gastric emptying tests, although the corr...

Lead sponsor: University of Auckland, New Zealand•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Genevieve M Johnston, PhD

CONTACT

+64 9 373 7599 gen.johnston@auckland.ac.nz

Sponsors

Lead Sponsor

University of Auckland, New Zealand

Collaborators

University of Western Sydney
Temple University
North Shore Hospital, New Zealand

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients 18 years of age and older
•Diagnosis of gastroparesis and/or functional dyspepsia
•Being prescribed a prokinetic agent or symptom modulator for their clinical care
•Able to undergo BSGM recording both before and during treatment
•Able to give informed consent for undergoing a baseline BSGM recording and an additional recording while on treatment

Exclusion Criteria

•Under 18 years of age
•Prior surgery on esophagus, stomach (appendectomy and cholecystectomy are allowed)
•History of skin allergies or a history of extreme sensitivity to cosmetics or lotions
•Pregnant women
•No vulnerable groups such as prisoners, individuals with known cognitive impairment, or institutionalized individuals be involved

Related studies

RECRUITINGEARLY Phase 1

Growth Hormone for the Treatment of Gastroparesis

NCT06803589 · Gastroparesis

Study of Gastric Motility in Eosinophilic Gastritis

NCT05229432 · Eosinophilic Gastritis, Gastroparesis, and more

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

NCT03876288 · Gastroparesis

Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms

NCT07442734 · Functional Dyspepsia, Insomnia, and more

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

NCT07287943 · Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 3, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment125

Start dateFeb 2025

Last updatedMar 3, 2025

Condition

Gastroparesis Functional Dyspepsia

Locations shown

Temple University

Philadelphia, Pennsylvania

Western Sydney University

Sydney, New South Wales

Te Whatu Ora Waitemata

Auckland, Auckland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions